Roche Holding AG (LTS:0QOK)
CHF 265.9 -1.15 (-0.43%) Market Cap: 211.97 Bil Enterprise Value: 237.60 Bil PE Ratio: 19.87 PB Ratio: 7.24 GF Score: 85/100

Roche Holding AG Virtual Event on Data Presented at American Society of Retina Specialists 38th Annual Meeting Transcript

Jul 27, 2020 / 02:30PM GMT
Release Date Price: CHF321.25 (+0.74%)
Operator

Ladies and gentlemen, welcome to the ASRS webinar. My name is Henrik, and I am the technical operator for today's call. Kindly note that the webinar is being recorded. (Operator Instructions)

At this time, it is my pleasure to introduce you to Karl Mahler, Head of Investor Relations and Group Planning. Karl, the stage is yours.

Karl Mahler
Roche Holding AG - Head of IR

Yes. Thanks a lot, Henrik. Welcome to all of you because of these ASRS Highlights 2020. Our virtual call to mainly present, but only -- not only to present the PDS data, but maybe, Lisa, if you could kindly go to the slide for the overview. Thank you. Thanks a lot.

So we have with us Atul Dandekar. He is the Vice President and Global Franchise Head of Ophthalmology. Atul will share with us the need, real-world outcomes that they have still significant room for improvement. He will talk about the PDS, the bispecific that they are addressing and it is addressing high medical needs. He will talk about our really broad pipeline. I think it's fair to say that we have the broadest

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot